Interstitial Lung Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Myositis Interstitial Lung Disease Nintedanib Trial
Condition: Myositis Associated Interstitial Lund Disease (MA-ILD) Interventions: Drug: Nintedanib; Drug: Placebo; Drug: Standard of Care Sponsors: Rohit Aggarwal, MD; Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2023 Category: Research Source Type: clinical trials
